Insider Transactions in Q2 2023 at Dia Medica Therapeutics Inc. (DMAC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
Thomas Von Koch > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,470,588
+25.37%
|
$4,411,764
$3.4 P/Share
|
|
Jun 23
2023
|
Randall Michael Giuffre Director |
SELL
Bona fide gift
|
Direct |
15,000
-4.16%
|
-
|
|
Jun 23
2023
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
65,000
+15.28%
|
$195,000
$3.91 P/Share
|
|
Jun 23
2023
|
Dietrich John Pauls President and CEO |
BUY
Open market or private purchase
|
Direct |
12,787
+15.71%
|
$38,361
$3.91 P/Share
|
|
Jun 23
2023
|
Charles Pauling Semba Director |
BUY
Open market or private purchase
|
Direct |
12,787
+29.93%
|
$38,361
$3.91 P/Share
|
|
Jun 23
2023
|
Scott Kellen CFO and Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+23.65%
|
$30,000
$3.91 P/Share
|
|
Jun 23
2023
|
David J. Wambeke Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
38,364
+7.03%
|
$115,092
$3.91 P/Share
|
|
Jun 23
2023
|
Richard D. Pilnik Director |
BUY
Open market or private purchase
|
Direct |
38,363
+13.39%
|
$115,089
$3.91 P/Share
|
|
Apr 10
2023
|
David J. Wambeke Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
468,750
+50.0%
|
$468,750
$1.6 P/Share
|